UROGEN PHARMA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.31 USD | -1.77% |
|
+0.53% | -11.27% |
| May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
| May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-28 | 2024-05-29 | 2024-05-30 | 2024-05-31 | |
|---|---|---|---|---|
| Last | 13.61 $ | 13.26 $ | 13.55 $ | 13.3 $ |
| Volume | 300 931 | 377 788 | 332 164 | 112 219 |
| Change | +2.79% | -2.57% | +2.19% | -1.85% |
| Opening | 13.00 | 13.40 | 13.40 | 13.61 |
| High | 13.75 | 13.57 | 13.83 | 13.84 |
| Low | 12.95 | 13.12 | 13.21 | 13.24 |
Performance
| 1 day | -1.77% | ||
| 1 week | +0.53% | ||
| Current month | +0.08% | ||
| 1 month | -7.57% | ||
| 3 months | -25.10% | ||
| 6 months | +2.15% | ||
| Current year | -11.27% | ||
| 1 year | +36.23% | ||
| 3 years | -29.43% | ||
| 5 years | -60.92% |
Volumes
marketsDaily volume
112 219
Estimated daily volume
112 219
Avg. Volume 20 sessions
333 382
Daily volume ratio
0.34
Avg. Volume 20 sessions USD
4 437 314.42
Record volume 1
9 466 033
Record volume 2
7 930 960
Record volume 3
3 245 234
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
480 530 609
Net sales (USD)
82 713 000
Number of employees
204
Sales / Employee (USD)
405 456
Free-Float
89.16 %
Free-Float capitalization (USD)
428 435 507
Average Daily Capital Traded
0.92%
Highs and lows
1 week
12.95
13.84
1 month
10.6014.89
Current year
10.6019.87
1 year
8.6924.13
3 years
4.8524.13
5 years
4.8538.03
10 years
4.8569.57
Indicators
Moving average 5 days
13.39
Moving average 20 days
13.35
Moving average 50 days
13.93
Moving average 100 days
15.28
Price spread / (MMA5)
+0.61%
Price spread / (MMA20)
+0.31%
Price spread / (MMA50)
+4.69%
Price spread / (MMA100)
+14.80%
STIM
RSI 9 days
52.73
RSI 14 days
49.54
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.77% | +0.53% | -11.27% | +36.23% | 481M | ||
| +2.77% | -0.35% | +11.91% | +40.70% | 118B | ||
| +1.06% | -0.49% | +11.60% | +34.05% | 106B | ||
| +1.87% | +3.76% | -4.68% | -3.38% | 24.28B | ||
| +1.04% | +0.89% | -0.82% | -6.84% | 21.96B | ||
| +0.31% | +0.55% | -10.12% | -29.18% | 18.16B | ||
| +0.41% | -1.50% | -42.12% | -37.24% | 16.37B | ||
| -3.50% | -2.53% | -17.47% | -33.39% | 15.56B | ||
| -0.91% | -2.86% | +2.77% | +48.49% | 13.63B | ||
| +4.28% | +5.12% | +34.58% | +4.43% | 12.27B | ||
| -3.39% | +150.23% | +77.64% | +186.12% | 8.87B | ||
| -1.71% | +3.60% | +7.26% | +53.59% | 7.75B | ||
| +0.09% | +2.20% | +11.89% | +39.70% | 7.65B | ||
| +0.25% | -1.43% | -3.92% | +25.16% | 7.42B | ||
| -7.66% | -3.38% | -33.51% | -37.11% | 7.29B | ||
| +0.78% | -0.78% | +234.55% | +183.39% | 6.87B | ||
| Average | -0.38% | +9.65% | +16.77% | +31.55% | ||
| Weighted average by Cap. | +1.05% | +3.41% | +10.16% | +27.49% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
5503e2675ba.StsegpYZy6DBI4kwAKtJL2SHPH4ZiaOhectz6Fk1Lu0.BuNf78BG_feFT9wAcNs-aDH2Uxxv4dfzOKUGuihGdoENjG7R33y7wYJRvQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:01 pm | 13.31 | 100 | 78,248 |
| 04:00:00 pm | 13.3 | 24,564 | 78,148 |
| 03:59:59 pm | 13.31 | 100 | 53,584 |
| 03:59:45 pm | 13.31 | 287 | 53,484 |
| 03:59:45 pm | 13.31 | 287 | 53,197 |
| 03:59:44 pm | 13.31 | 100 | 52,910 |
| 03:59:15 pm | 13.3 | 100 | 52,810 |
| 03:59:04 pm | 13.31 | 145 | 52,710 |
| 03:59:04 pm | 13.31 | 100 | 52,565 |
| 03:58:58 pm | 13.3 | 100 | 52,465 |
Monthly variations
Annual change
| 2024 | -11.33% | ||
| 2023 | +69.11% | ||
| 2022 | -6.73% | ||
| 2021 | -47.23% | ||
| 2020 | -46.00% | ||
| 2019 | -22.50% | ||
| 2018 | +15.72% | ||
| 2017 | +166.17% |
- Stock Market
- Equities
- URGN Stock
- Quotes UroGen Pharma Ltd.
